Evidence map›Paper›PMID 41626918›Full record

ArticleResearch synthesis methods2025

One-step parametric network meta-analysis models using the exact likelihood that allow for time-varying treatment effects.

Harlan Campbell, Dylan Maciel, Keith Chan, Jeroen P Jansen, Sven Klijn, Kevin Towle, Bill Malcolm, Shannon Cope

Abstract read
In one paragraph

Article in Research synthesis methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Harlan CampbellHealth Economics and Outcomes Research, Precision AQ, Vancouver, BC, Canada.
Dylan MacielHealth Economics and Outcomes Research, Precision AQ, Vancouver, BC, Canada.
Keith ChanHealth Economics and Outcomes Research, Precision AQ, Vancouver, BC, Canada.
Jeroen P JansenHealth Economics and Outcomes Research, Precision AQ, Vancouver, BC, Canada.
Sven KlijnBristol Myers Squibb, Princeton, NJ, USA.
Kevin TowleHealth Economics and Outcomes Research, Precision AQ, Vancouver, BC, Canada.
Bill MalcolmBristol Myers Squibb, Uxbridge, UK.
Shannon CopeHealth Economics and Outcomes Research, Precision AQ, Vancouver, BC, Canada.

Funding

Bristol-Myers Squibb
6 · The paper itself

Abstract

The importance of network meta-analysis (NMA) methods for time-to-event (TTE) that do not rely on the proportional hazard (PH) assumption is increasingly recognized in oncology, where clinical trials evaluating new interventions versus standard comparators often violate this assumption. However, existing NMA methods that allow for time-varying treatment effects do not directly leverage individual events and censor times that can be reconstructed from Kaplan-Meier curves, which may be more accurate than discrete hazards. They are also challenging to implement given reparameterizations that rely on discrete hazards. Additionally, two-step methods require assumptions regarding within-study normality and variance. We propose a one-step fully Bayesian parametric individual patient data (IPD)-NMA model that fits TTE data with the exact likelihood and allows for time-varying treatment effects. We define fixed or random effects with the following distributions: Weibull, Gompertz, log-normal, log-logistic, gamma, or generalized gamma distributions. We apply the one-step model to a network of randomized controlled trials (RCTs) evaluating multiple interventions for advanced melanoma and compare results with those obtained with the two-step approach. Additionally, a simulation study was performed to compare the proposed one-step method to the two-step method. The one-step method allows for straightforward model selection among the "standard" distributions, now including gamma and generalized gamma, with treatment effects on either the scale alone or with multivariate treatment effects. Generalized gamma offers flexibility to model U-shaped hazards within a network of RCTs, with accessible interpretation of parameters that simplifies to exponential, Weibull, log-normal, or gamma in special cases.

Indexed as

Network Meta-Analysis as TopicAlgorithmsBayes TheoremComputer SimulationData Interpretation, StatisticalHumansKaplan-Meier EstimateLikelihood FunctionsMelanomaModels, StatisticalProportional Hazards ModelsRandomized Controlled Trials as TopicResearch DesignTime FactorsTreatment Outcomecomparative effectiveness researchevidence synthesisnetwork meta-analysisparametric modelstime-to-event outcomes

Identifiers

PMID41626918
PMCPMC12527511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.